peptide elongation factor 2 has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buerkle, H; Erxleben, A; Guelzow, T; Heimrich, B; Humar, M; Lehane, C; Schwer, CI; Spassov, S; Strosing, KM; Zenker, S | 1 |
| Burda, J; García, L; Martín, ME; O'Loghlen, A; Salinas, M | 1 |
2 other study(ies) available for peptide elongation factor 2 and Brain Ischemia
| Article | Year |
|---|---|
Thiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell death.
Topics: Animals; Brain Injuries; Brain Ischemia; Cell Death; Cell Hypoxia; Cell Line; Elongation Factor 2 Kinase; Humans; Hypnotics and Sedatives; Mice; Neurons; Oxygen; Peptide Elongation Factor 2; Protein Biosynthesis; Thiopental | 2013 |
Does phosphorylation of eukaryotic elongation factor eEF2 regulate protein synthesis in ischemic preconditioning?
Topics: Animals; Brain; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Down-Regulation; Hippocampus; Hydrogen Peroxide; Ischemic Preconditioning; Nerve Tissue Proteins; Oxidative Stress; Peptide Elongation Factor 2; Phosphorylation; Rats; Rats, Wistar; Reaction Time; Reperfusion Injury | 2004 |